These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
338 related articles for article (PubMed ID: 22270997)
1. Evaluation of postoperative radioactive iodine scans in patients who underwent prophylactic central lymph node dissection. Laird AM; Gauger PG; Miller BS; Doherty GM World J Surg; 2012 Jun; 36(6):1268-73. PubMed ID: 22270997 [TBL] [Abstract][Full Text] [Related]
2. Prophylactic central lymph node dissection informs the decision of radioactive iodine ablation in papillary thyroid cancer. Nylén C; Eriksson FB; Yang A; Aniss A; Turchini J; Learoyd D; Robinson BG; Gill AJ; Clifton-Bligh RJ; Sywak MS; Glover AR; Sidhu SB Am J Surg; 2021 May; 221(5):886-892. PubMed ID: 32878695 [TBL] [Abstract][Full Text] [Related]
3. Prophylactic central lymph node dissection for clinically node-negative papillary thyroid microcarcinoma: influence on serum thyroglobulin level, recurrence rate, and postoperative complications. So YK; Seo MY; Son YI Surgery; 2012 Feb; 151(2):192-8. PubMed ID: 21497873 [TBL] [Abstract][Full Text] [Related]
4. Knowledge of pathologically versus clinically negative lymph nodes is associated with reduced use of radioactive iodine post-thyroidectomy for low-risk papillary thyroid cancer. Ruel E; Thomas S; Dinan MA; Perkins JM; Roman SA; Sosa JA Endocrine; 2016 Jun; 52(3):579-86. PubMed ID: 26708045 [TBL] [Abstract][Full Text] [Related]
5. The need of prophylactic central lymph node dissection is controversial in terms of postoperative thyroglobulin follow-up of patients with cN0 papillary thyroid cancer. Korkmaz MH; Öcal B; Saylam G; Çakal E; Bayır Ö; Tutal E; Tatar EÇ Langenbecks Arch Surg; 2017 Mar; 402(2):235-242. PubMed ID: 28224278 [TBL] [Abstract][Full Text] [Related]
6. Clinical response to radioactive iodine therapy for prophylactic central neck dissection is not superior to total thyroidectomy alone in cN0 patients with papillary thyroid cancer. Lin B; Qiang W; Wenqi Z; Tianyu Y; Lina Z; Bin J Nucl Med Commun; 2017 Dec; 38(12):1036-1040. PubMed ID: 28953211 [TBL] [Abstract][Full Text] [Related]
7. A multicenter cohort study of total thyroidectomy and routine central lymph node dissection for cN0 papillary thyroid cancer. Popadich A; Levin O; Lee JC; Smooke-Praw S; Ro K; Fazel M; Arora A; Tolley NS; Palazzo F; Learoyd DL; Sidhu S; Delbridge L; Sywak M; Yeh MW Surgery; 2011 Dec; 150(6):1048-57. PubMed ID: 22136820 [TBL] [Abstract][Full Text] [Related]
8. Level VI lymph node dissection does not decrease radioiodine uptake in patients undergoing radioiodine ablation for differentiated thyroid cancer. Yoo D; Ajmal S; Gowda S; Machan J; Monchik J; Mazzaglia P World J Surg; 2012 Jun; 36(6):1255-61. PubMed ID: 22430670 [TBL] [Abstract][Full Text] [Related]
9. Impact of prophylactic central neck lymph node dissection on early recurrence in papillary thyroid carcinoma. Moo TA; McGill J; Allendorf J; Lee J; Fahey T; Zarnegar R World J Surg; 2010 Jun; 34(6):1187-91. PubMed ID: 20130868 [TBL] [Abstract][Full Text] [Related]
10. Predictors of response to Radioactive Iodine Therapy in Intermediate and high risk patients with papillary thyroid carcinoma. Keshavarzi A; Alaei-Shahmiri F; Fallahi B; Emami Z; Malek M; Khamseh ME BMC Endocr Disord; 2024 Jul; 24(1):112. PubMed ID: 39004697 [TBL] [Abstract][Full Text] [Related]
11. Post-operative stimulated thyroglobulin and neck ultrasound as personalized criteria for risk stratification and radioactive iodine selection in low- and intermediate-risk papillary thyroid cancer. Orlov S; Salari F; Kashat L; Freeman JL; Vescan A; Witterick IJ; Walfish PG Endocrine; 2015 Sep; 50(1):130-7. PubMed ID: 25792004 [TBL] [Abstract][Full Text] [Related]
12. Influence of prophylactic central lymph node dissection on postoperative thyroglobulin levels and radioiodine treatment in papillary thyroid cancer. Hughes DT; White ML; Miller BS; Gauger PG; Burney RE; Doherty GM Surgery; 2010 Dec; 148(6):1100-6; discussion 1006-7. PubMed ID: 21134539 [TBL] [Abstract][Full Text] [Related]
13. Prophylactic Central Neck Dissection in Papillary Thyroid Carcinoma: All Risks, No Reward. Dismukes J; Fazendin J; Obiarinze R; Márquez GCH; Ramonell KM; Buczek E; Lindeman B; Chen H J Surg Res; 2021 Aug; 264():230-235. PubMed ID: 33838407 [TBL] [Abstract][Full Text] [Related]
14. Postoperative recurrence of papillary thyroid carcinoma with lymph node metastasis. Liu FH; Kuo SF; Hsueh C; Chao TC; Lin JD J Surg Oncol; 2015 Aug; 112(2):149-54. PubMed ID: 26175314 [TBL] [Abstract][Full Text] [Related]
15. Robotic total thyroidectomy with modified radical neck dissection via unilateral retroauricular approach. Byeon HK; Holsinger FC; Tufano RP; Chung HJ; Kim WS; Koh YW; Choi EC Ann Surg Oncol; 2014 Nov; 21(12):3872-5. PubMed ID: 25227305 [TBL] [Abstract][Full Text] [Related]
16. Rationality in prophylactic central neck dissection in clinically node-negative (cN0) papillary thyroid carcinoma: Is there anything more to say? A decade experience in a single-center. Dobrinja C; Troian M; Cipolat Mis T; Rebez G; Bernardi S; Fabris B; Piscopello L; Makovac P; Di Gregorio F; de Manzini N Int J Surg; 2017 May; 41 Suppl 1():S40-S47. PubMed ID: 28506412 [TBL] [Abstract][Full Text] [Related]
17. Significance of size of lymph node metastasis on postsurgical stimulated thyroglobulin levels after prophylactic unilateral central neck dissection in papillary thyroid carcinoma. Lang BH; Tang AH; Wong KP; Shek TW; Wan KY; Lo CY Ann Surg Oncol; 2012 Oct; 19(11):3472-8. PubMed ID: 22565664 [TBL] [Abstract][Full Text] [Related]
18. Is Postoperative Adjuvant Radioactive Iodine Ablation Therapy Always Necessary for Intermediate-Risk Papillary Thyroid Cancer Patients With Central Neck Metastasis? Han K; Noh HM; Jeong HM; Lim YC Ann Surg Oncol; 2021 Nov; 28(12):7533-7544. PubMed ID: 34043093 [TBL] [Abstract][Full Text] [Related]
19. Prognostic factors for recurrence of papillary thyroid carcinoma in the lymph nodes, lung, and bone: analysis of 5,768 patients with average 10-year follow-up. Ito Y; Kudo T; Kobayashi K; Miya A; Ichihara K; Miyauchi A World J Surg; 2012 Jun; 36(6):1274-8. PubMed ID: 22270990 [TBL] [Abstract][Full Text] [Related]
20. Central lymph node dissection as a secondary procedure for papillary thyroid cancer: Is there added morbidity? Alvarado R; Sywak MS; Delbridge L; Sidhu SB Surgery; 2009 May; 145(5):514-8. PubMed ID: 19375610 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]